Efficacy of Different Treatment Regimens for Antiphospholipid Syndrome-related Recurrent Spontaneous Abortion
Background: Antiphospholipid syndrome (APS)-related immune factors are considered as an important cause of recurrent spontaneous abortion (RSA). Anticoagulant and anti-inflammatory treatments are believed to effectively improve adverse pregnancy outcomes by affecting the abnormal autoimmune response...
Main Authors: | Sheng-Long Ye, Xun-Ke Gu, Li-Yuan Tao, Ji-Mei Cong, Yong-Qing Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2017-01-01
|
Series: | Chinese Medical Journal |
Subjects: | |
Online Access: | http://www.cmj.org/article.asp?issn=0366-6999;year=2017;volume=130;issue=12;spage=1395;epage=1399;aulast=Ye |
Similar Items
-
Antiphospholipid Antibodies in Iraqi Women with Recurrent Mid-Trimester Abortions
by: Amel AA Al-Samarrai, et al.
Published: (2012-07-01) -
Anticardiolipin antibody in recurrent spontaneous aborting and fertile women
by: Egle Couto, et al. -
Frequency of Protein C, S and Antithrombin III Deficiency and Presence of Antibodies of Antiphospholipid Syndrome in Women with Recurrent Abortion
by: Mohammad Matin, et al.
Published: (2019-07-01) -
Retrospective Analysis of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Women With Recurrent Spontaneous Abortion
by: Long Zhao, et al.
Published: (2021-10-01) -
Antiphospholipid Antibody Syndrome and Infertility
by: Vivian de Oliveira Rodrigues, et al.
Published: (2019-11-01)